Elsevier

Gastrointestinal Endoscopy

Volume 90, Issue 3, September 2019, Pages 335-359.e2
Gastrointestinal Endoscopy

Guideline
ASGE guideline on screening and surveillance of Barrett’s esophagus

https://doi.org/10.1016/j.gie.2019.05.012Get rights and content

Section snippets

General Considerations for Screening and Surveillance

Screening is the mechanism through which populations may be assessed to identify individuals who have a disease or a preclinical condition that predisposes to a disease. Surveillance is the program through which these at-risk individuals are periodically assessed or examined to identify disease at a stage amenable to cure.15 The evidence to support screening and surveillance endoscopy, a practice that has been recommended by national guidelines,4, 12, 13, 14 is highly variable and based on

Aims and Scope

The aim of this document is to offer evidence-based recommendations and clinical guidelines addressing key issues related to screening and surveillance in patients with BE. The panel considered the following clinical questions:

  • What is the role of surveillance endoscopy in patients with NDBE compared with no surveillance in decreasing the rate of cancer progression, EAC-related mortality, and all-cause mortality?

  • What is the role of screening for BE in the general population and at-risk

Overview

This guideline document was based on systematic reviews (SRs) of the available literature for each clinical question. The quality or certainty in the evidence and strength of recommendations was based on the GRADE framework. When existing SRs were identified, they were used to inform the guideline when appropriate. If no existing SRs were found, a new SR (and meta-analysis [MA], when possible) was conducted with the help of an expert librarian. Evidence profiles were created with the help of

Results

The recommendations for each clinical question are summarized in Table 4.

Question 1: What is the role of surveillance endoscopy in patients with NDBE compared with no surveillance in decreasing the rate of cancer progression, EAC-related mortality, and all-cause mortality?

Recommendation: In patients with NDBE, we suggest performing surveillance endoscopy compared with no surveillance (conditional recommendation, very low quality of evidence).

Summary of the evidence: Surveillance endoscopy for

Future Directions

This document highlights several knowledge gaps in the field of screening and surveillance for BE. First and foremost, we still lack high-quality evidence on the benefits of screening and surveillance in patients with BE specifically addressing key outcomes such as incidence, morbidity, and mortality associated with EAC. In this document, we discuss the best design for future studies to address this critical issue. Future studies that refine and validate existing prediction tools for screening

Summary and Conclusions

In this document, the ASGE offers evidence-based clinical practice guidelines on topics regarding screening and surveillance for BE. These guidelines follow the GRADE framework and offer guidance on several key clinical questions such as the role and impact of screening and surveillance in patients with BE and the role of advanced imaging techniques in BE patients undergoing surveillance endoscopy. This guideline complies with the standards for guideline development set forth by the Institute

Acknowledgment

The panel thanks John Bastian for his contributions from the patient perspective.

References (119)

  • J.A. Abrams et al.

    Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States

    Clin Gastroenterol Hepatol

    (2009)
  • S. Wani et al.

    Training in EUS and ERCP: standardizing methods to assess competence

    Gastrointest Endosc

    (2018)
  • J.A.Z. Jankowski et al.

    Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial

    Lancet

    (2018)
  • S.J. Spechler et al.

    New screening techniques in Barrett's esophagus: great ideas or great practice?

    Gastroenterology

    (2018)
  • D.K. Rex et al.

    Screening for Barrett's esophagus in colonoscopy patients with and without heartburn

    Gastroenterology

    (2003)
  • L.B. Gerson et al.

    Prevalence of Barrett's esophagus in asymptomatic individuals

    Gastroenterology

    (2002)
  • J.H. Rubenstein et al.

    Risk factors and populations at risk: selection of patients for screening for Barrett's oesophagus

    Best Pract Res Clin Gastroenterol

    (2015)
  • A. Mussetto et al.

    Screening for Barrett's oesophagus with oesophageal capsule endoscopy in first-degree relatives of patients affected by Barrett's oesophagus: results of a pilot study

    Arab J Gastroenterol

    (2013)
  • P. Sharma et al.

    The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on imaging in Barrett's esophagus

    Gastrointest Endosc

    (2012)
  • W.L. Curvers et al.

    Endoscopic trimodal imaging versus standard video endoscopy for detection of early Barrett's neoplasia: a multicenter, randomized, crossover study in general practice

    Gastrointest Endosc

    (2011)
  • J.R. Olliver et al.

    Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus

    Lancet

    (2003)
  • H. Kondo et al.

    Sodium thiosulfate solution spray for relief of irritation caused by Lugol's stain in chromoendoscopy

    Gastrointest Endosc

    (2001)
  • S. Wani et al.

    Endoscopic surface imaging of Barrett's esophagus: an optimistic view

    Gastroenterology

    (2007)
  • P. Sharma et al.

    Development and validation of a classification system to identify high-grade dysplasia and esophageal adenocarcinoma in Barrett's esophagus using narrow-band imaging

    Gastroenterology

    (2016)
  • M.I. Canto et al.

    In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia: a multicenter international randomized controlled trial (with video)

    Gastrointest Endosc

    (2014)
  • K.B. Dunbar et al.

    Confocal laser endomicroscopy in Barrett's esophagus and endoscopically inapparent Barrett's neoplasia: a prospective, randomized, double-blind, controlled, crossover trial

    Gastrointest Endosc

    (2010)
  • P. Sharma et al.

    Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial

    Gastrointest Endosc

    (2011)
  • S.S. Chauhan et al.

    Confocal laser endomicroscopy

    Gastrointest Endosc

    (2014)
  • M. Saumoy et al.

    Cost-utility analysis for surveillance of Barrett's esophagus evaluating standard biopsies compared to optical coherence tomography and confocal laser endomicroscopy [abstract]

    Gastrointest Endosc

    (2017)
  • B.J. Qumseya et al.

    High rate of over-staging of Barrett's neoplasia with endoscopic ultrasound: Systemic review and meta-analysis

    Dig Liver Dis

    (2018)
  • M.J. Bartel et al.

    Role of EUS in patients with suspected Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma: impact on endoscopic therapy

    Gastrointest Endosc

    (2017)
  • A. Das et al.

    Cervical esophageal perforation during EUS: a national survey

    Gastrointest Endosc

    (2001)
  • K.X. Wang et al.

    Assessment of morbidity and mortality associated with EUS-guided FNA: a systematic review

    Gastrointest Endosc

    (2011)
  • S. Wani et al.

    Endoscopic eradication therapy for patients with Barrett's esophagus-associated dysplasia and intramucosal cancer

    Gastrointest Endosc

    (2018)
  • N.J. Shaheen et al.

    ACG clinical guideline: diagnosis and management of Barrett's esophagus

    Am J Gastroenterol

    (2016)
  • A.P. Thrift

    Barrett's esophagus and esophageal adenocarcinoma: How common are they really?

    Dig Dis Sci

    (2018)
  • J.H. Rubenstein et al.

    Epidemiology, diagnosis, and management of esophageal adenocarcinoma

    Gastroenterology

    (2015)
  • C. Hur et al.

    Trends in esophageal adenocarcinoma incidence and mortality

    Cancer

    (2013)
  • N.J. Shaheen et al.

    Radiofrequency ablation in Barrett's esophagus with dysplasia

    N Engl J Med

    (2009)
  • A.J. Small et al.

    Radiofrequency ablation is associated with decreased neoplastic progression in patients with barrett's esophagus and confirmed low-grade dysplasia

    Gastroenterology

    (2015)
  • B.J. Qumseya et al.

    Disease progression in Barrett's low-grade dysplasia with radiofrequency ablation compared with surveillance: systematic review and meta-analysis

    Am J Gastroenterol

    (2017)
  • S.J. Spechler et al.

    American Gastroenterological Association medical position statement on the management of Barrett's esophagus

    Gastroenterology

    (2011)
  • R.C. Fitzgerald et al.

    British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus

    Gut

    (2014)
  • B. Weusten et al.

    Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement

    Endoscopy

    (2017)
  • J.E. Abela et al.

    Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy

    Am J Gastroenterol

    (2008)
  • G.H. Guyatt et al.

    GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

    BMJ

    (2008)
  • D.C. Codipilly et al.

    The effect of endoscopic surveillance in patients with Barrett's esophagus: a systematic review and meta-analysis

    Gastroenterology

    (2018)
  • H.B. El-Serag et al.

    Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus

    Gut

    (2016)
  • A.C. Tramontano et al.

    The impact of a prior diagnosis of Barrett's esophagus on esophageal adenocarcinoma survival

    Am J Gastroenterol

    (2017)
  • B.J. Qumseya et al.

    Adverse events after radiofrequency ablation in patients with Barrett's esophagus: a systematic review and meta-analysis

    Clin Gastroenterol Hepatol

    (2016)
  • Cited by (249)

    • The Role of Screening and Early Detection in Upper Gastrointestinal Cancers

      2024, Hematology/Oncology Clinics of North America
    View all citing articles on Scopus

    The final document was approved by the ASGE Governing Board and the Standards of Practice Committee and represents the official guideline of the ASGE on these topics.

    DISCLOSURE: The following authors disclosed financial relationships relevant to this publication: M. Al-Haddad: Teaching and research support from Boston Scientific. J. Buxbaum: Consultant for Olympus. J. Dewitt: Consultant for Olympus America and Boston Scientific; grant support from Pinnacle Biologics. D. Fishman: Contributor to UpToDate. B. Jacobson: Consultant for Motus GI, Remedy Partners, and Dark Canyon, LLC. L. Jamil: Consultant and speaker for Aries Pharmaceutical. M. Khashab: Consultant and medical advisory board for Boston Scientific and Olympus; consultant for Medtronic. M. McCarter: Medical advisory board for Debbies Dream Foundation. N. Thosani: Consultant for Pentax America, Boston Scientific, Medtronic, and Endogastric Solutions; speaker for AbbVie. S. Wani: Consultant for Medtronic and Boston Scientific; supported by University of Colorado Department of Medicine Outstanding Early Scholars Program. All other authors disclosed no financial relationships relevant to this publication.

    Drs Qumseya and Sultan contributed equally to this article.

    View full text